Prolaris + AI
Prostate cancer prognostic/treatment-guidance test combining molecular score with clinical/pathology and AI.
- Developer
- Myriad Genetics
- Intended use
- Risk Stratification
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- RNA expression
- Current version
- Prolaris + AI
- Evidence context
- 1 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.